SIGA
SIGA Technologies, Inc.
Drug Manufacturers - Specialty & Generic
Market Cap$337M
5Y Perf.-21.5%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
SIGA vs GILD
Revenue, margins, valuation, and 5-year total return — side by side.
GILD
Gilead Sciences, Inc.
Drug Manufacturers - General
Market Cap$169.83B
5Y Perf.+75.1%
SIGA vs GILD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | SIGA | GILD |
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - General |
| Market Cap | $337M | $169.83B |
| Revenue (TTM) | $95M | $29.44B |
| Net Income (TTM) | $23M | $8.51B |
| Gross Margin | 68.6% | 80.8% |
| Operating Margin | 25.1% | 37.4% |
| Forward P/E | 2.8x | 15.9x |
| Total Debt | $795K | $26.71B |
| Cash & Equiv. | $154.97T | $9.99B |
SIGA vs GILD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
SIGA
GILD
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SIGA Technologies, … (SIGA) | 100 | 78.5 | -21.5% |
| Gilead Sciences, In… (GILD) | 100 | 175.1 | +75.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SIGA vs GILD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: GILD leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. SIGA Technologies, Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
SIGA
SIGA Technologies, Inc.
The Long-Run Compounder
SIGA is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 7.2% 10Y total return vs GILD's 92.6%
- Lower volatility, beta 1.15, Low D/E 0.0%, current ratio 11.83x
- Beta 1.15, yield 12.8%, current ratio 11.83x
Best for: long-term compounding and sleep-well-at-night
GILD
Gilead Sciences, Inc.
The Income Pick
GILD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 10 yrs, beta 0.66, yield 2.3%
- Rev growth 6.0%, EPS growth -91.6%, 3Y rev CAGR 1.7%
- 6.0% revenue growth vs SIGA's -31.8%
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | GILD | 6.0% revenue growth vs SIGA's -31.8% |
| Value | SIGA | Lower P/E (2.8x vs 15.9x) |
| Quality / Margins | GILD | 28.9% margin vs SIGA's 24.6% |
| Stability / Safety | GILD | Beta 0.66 vs SIGA's 1.15 |
| Dividends | SIGA | 12.8% yield, 4-year raise streak, vs GILD's 2.3% |
| Momentum (1Y) | GILD | +42.5% vs SIGA's +0.6% |
| Efficiency (ROA) | GILD | 14.4% ROA vs SIGA's 0.0%, ROIC 3.2% vs 0.0% |
SIGA vs GILD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2024
SIGA vs GILD — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLGILDLAGGINGSIGA
SIGASIGA Technologies, In…
1leads
GILDGilead Sciences, Inc.
4leads
6 Total Categories
CATEGORYLEADERvs SIGAMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
GILD5/6
Valuation MetricsMultiples, price ratios, and targets
SIGA6/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
GILD5/8
Total Returns1Y, 3Y, 5Y total returns with dividends
GILD5/6
Risk & VolatilityBeta, volatility, and downside exposure
GILD2/2
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
GILD leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GILD is the larger business by revenue, generating $29.4B annually — 311.3x SIGA's $95M. Profitability is closely matched — net margins range from 28.9% (GILD) to 24.6% (SIGA). On growth, GILD holds the edge at +4.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SIGASIGA Technologies… | GILDGilead Sciences, … |
|---|---|---|
| RevenueTrailing 12 months | $95M | $29.4B |
| EBITDAEarnings before interest/tax | $24M | $12.4B |
| Net IncomeAfter-tax profit | $23M | $8.5B |
| Free Cash FlowCash after capex | $49M | $9.7B |
| Gross MarginGross profit ÷ Revenue | +68.6% | +80.8% |
| Operating MarginEBIT ÷ Revenue | +25.1% | +37.4% |
| Net MarginNet income ÷ Revenue | +24.6% | +28.9% |
| FCF MarginFCF ÷ Revenue | +51.5% | +32.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -95.3% | +4.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -111.8% | +22.5% |
GILD leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
SIGA leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 14.2x trailing earnings, SIGA trades at a 96% valuation discount to GILD's 358.7x P/E.
| Metric | SIGASIGA Technologies… | GILDGilead Sciences, … |
|---|---|---|
| Market CapShares × price | $337M | $169.8B |
| Enterprise ValueMkt cap + debt − cash | -$154.97T | $186.5B |
| Trailing P/EPrice ÷ TTM EPS | 14.24x | 358.68x |
| Forward P/EPrice ÷ next-FY EPS est. | 2.76x | 15.95x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | -6387033.21x | 42.12x |
| Price / SalesMarket cap ÷ Revenue | 3.56x | 5.91x |
| Price / BookPrice ÷ Book value/share | 0.00x | 8.89x |
| Price / FCFMarket cap ÷ FCF | 6.91x | 16.48x |
SIGA leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
GILD leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
GILD delivers a 37.6% return on equity — every $100 of shareholder capital generates $38 in annual profit, vs $0 for SIGA. SIGA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to GILD's 1.39x. On the Piotroski fundamental quality scale (0–9), GILD scores 7/9 vs SIGA's 5/9, reflecting strong financial health.
| Metric | SIGASIGA Technologies… | GILDGilead Sciences, … |
|---|---|---|
| ROE (TTM)Return on equity | 0.0% | +37.6% |
| ROA (TTM)Return on assets | 0.0% | +14.4% |
| ROICReturn on invested capital | +0.0% | +3.2% |
| ROCEReturn on capital employed | 0.0% | +3.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.00x | 1.39x |
| Net DebtTotal debt minus cash | -$154.97T | $16.7B |
| Cash & Equiv.Liquid assets | $154.97T | $10.0B |
| Total DebtShort + long-term debt | $795,169 | $26.7B |
| Interest CoverageEBIT ÷ Interest expense | — | 10.56x |
GILD leads this category, winning 5 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
GILD leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GILD five years ago would be worth $22,755 today (with dividends reinvested), compared to $10,096 for SIGA. Over the past 12 months, GILD leads with a +42.5% total return vs SIGA's +0.6%. The 3-year compound annual growth rate (CAGR) favors GILD at 22.8% vs SIGA's 6.8% — a key indicator of consistent wealth creation.
| Metric | SIGASIGA Technologies… | GILDGilead Sciences, … |
|---|---|---|
| YTD ReturnYear-to-date | -15.5% | +12.8% |
| 1-Year ReturnPast 12 months | +0.6% | +42.5% |
| 3-Year ReturnCumulative with dividends | +21.7% | +85.3% |
| 5-Year ReturnCumulative with dividends | +1.0% | +127.5% |
| 10-Year ReturnCumulative with dividends | +722.2% | +92.6% |
| CAGR (3Y)Annualised 3-year return | +6.8% | +22.8% |
GILD leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
GILD leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GILD is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than SIGA's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GILD currently trades 86.7% from its 52-week high vs SIGA's 48.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SIGASIGA Technologies… | GILDGilead Sciences, … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.15x | 0.66x |
| 52-Week HighHighest price in past year | $9.62 | $157.29 |
| 52-Week LowLowest price in past year | $4.29 | $95.30 |
| % of 52W HighCurrent price vs 52-week peak | +48.9% | +86.7% |
| RSI (14)Momentum oscillator 0–100 | 44.0 | 45.3 |
| Avg Volume (50D)Average daily shares traded | 683K | 5.8M |
GILD leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Evenly matched — SIGA and GILD each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates SIGA as "Buy" and GILD as "Buy". For income investors, SIGA offers the higher dividend yield at 12.81% vs GILD's 2.29%.
| Metric | SIGASIGA Technologies… | GILDGilead Sciences, … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $161.88 |
| # AnalystsCovering analysts | 1 | 58 |
| Dividend YieldAnnual dividend ÷ price | +12.8% | +2.3% |
| Dividend StreakConsecutive years of raises | 4 | 10 |
| Dividend / ShareAnnual DPS | $0.60 | $3.12 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.7% |
Evenly matched — SIGA and GILD each lead in 1 of 2 comparable metrics.
Key Takeaway
GILD leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SIGA leads in 1 (Valuation Metrics). 1 tied.
Best OverallGilead Sciences, Inc. (GILD)Leads 4 of 6 categories
Loading custom metrics...
SIGA vs GILD: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is SIGA or GILD a better buy right now?
For growth investors, Gilead Sciences, Inc.
(GILD) is the stronger pick with 6. 0% revenue growth year-over-year, versus -31. 8% for SIGA Technologies, Inc. (SIGA). SIGA Technologies, Inc. (SIGA) offers the better valuation at 14. 2x trailing P/E (2. 8x forward), making it the more compelling value choice. Analysts rate SIGA Technologies, Inc. (SIGA) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SIGA or GILD?
On trailing P/E, SIGA Technologies, Inc.
(SIGA) is the cheapest at 14. 2x versus Gilead Sciences, Inc. at 358. 7x. On forward P/E, SIGA Technologies, Inc. is actually cheaper at 2. 8x.
03Which is the better long-term investment — SIGA or GILD?
Over the past 5 years, Gilead Sciences, Inc.
(GILD) delivered a total return of +127. 5%, compared to +1. 0% for SIGA Technologies, Inc. (SIGA). Over 10 years, the gap is even starker: SIGA returned +722. 2% versus GILD's +92. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SIGA or GILD?
By beta (market sensitivity over 5 years), Gilead Sciences, Inc.
(GILD) is the lower-risk stock at 0. 66β versus SIGA Technologies, Inc. 's 1. 15β — meaning SIGA is approximately 75% more volatile than GILD relative to the S&P 500. On balance sheet safety, SIGA Technologies, Inc. (SIGA) carries a lower debt/equity ratio of 0% versus 139% for Gilead Sciences, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SIGA or GILD?
By revenue growth (latest reported year), Gilead Sciences, Inc.
(GILD) is pulling ahead at 6. 0% versus -31. 8% for SIGA Technologies, Inc. (SIGA). On earnings-per-share growth, the picture is similar: SIGA Technologies, Inc. grew EPS -60. 2% year-over-year, compared to -91. 6% for Gilead Sciences, Inc.. Over a 3-year CAGR, GILD leads at 1. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SIGA or GILD?
SIGA Technologies, Inc.
(SIGA) is the more profitable company, earning 24. 6% net margin versus 1. 7% for Gilead Sciences, Inc. — meaning it keeps 24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIGA leads at 25. 1% versus 5. 8% for GILD. At the gross margin level — before operating expenses — GILD leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SIGA or GILD more undervalued right now?
On forward earnings alone, SIGA Technologies, Inc.
(SIGA) trades at 2. 8x forward P/E versus 15. 9x for Gilead Sciences, Inc. — 13. 2x cheaper on a one-year earnings basis.
08Which pays a better dividend — SIGA or GILD?
All stocks in this comparison pay dividends.
SIGA Technologies, Inc. (SIGA) offers the highest yield at 12. 8%, versus 2. 3% for Gilead Sciences, Inc. (GILD).
09Is SIGA or GILD better for a retirement portfolio?
For long-horizon retirement investors, Gilead Sciences, Inc.
(GILD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 66), 2. 3% yield). Both have compounded well over 10 years (GILD: +92. 6%, SIGA: +722. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SIGA and GILD?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SIGA is a small-cap deep-value stock; GILD is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(SIGA: -95.3% · GILD: 4.7%)Net Margin>
%
(SIGA: 24.6% · GILD: 28.9%)P/E Ratio<
x
(SIGA: 14.2x · GILD: 358.7x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.